M&T Bank Corp Heron Therapeutics, Inc. Transaction History

M&T Bank Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.51 - $3.25 $89,153 - $191,886	-59,042 Reduced 39.81%	89,280 $134,000
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $91,325 - $189,550	40,589 Added 37.68%	148,322 $370,000
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $106,202 - $220,428	47,201 Added 77.98%	107,733 $269,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $23,434 - $47,309	8,810 Added 17.03%	60,532 $256,000
Q2 2022 Aug 05, 2022	BUY	$2.3 - $6.29 $61,800 - $169,012	26,870 Added 108.12%	51,722 $144,000
Q1 2022 May 09, 2022	BUY	$4.63 - $9.94 $9,556 - $20,516	2,064 Added 9.06%	24,852 $142,000
Q4 2021 Feb 07, 2022	BUY	$8.35 - $12.6 $10,379 - $15,661	1,243 Added 5.77%	22,788 $208,000
Q1 2021 May 06, 2021	BUY	$14.49 - $20.72 $35,688 - $51,033	2,463 Added 12.91%	21,545 $349,000
Q3 2020 Nov 06, 2020	BUY	$13.67 - $17.77 $57,496 - $74,740	4,206 Added 28.27%	19,082 $282,000
Q2 2020 Jul 29, 2020	BUY	$10.89 - $21.47 $23,250 - $45,838	2,135 Added 16.76%	14,876 $219,000
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $17,841 - $42,832	1,744 Added 15.86%	12,741 $150,000
Q4 2019 Feb 07, 2020	SELL	$17.42 - $26.61 $243 - $372	-14 Reduced 0.13%	10,997 $258,000
Q3 2019 Nov 12, 2019	BUY	$16.36 - $21.39 $180,139 - $235,525	11,011 New	11,011 $204,000

173

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $285M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.